Oppes M - Search Results

1

A reevaluation of methodological aspects of a commercial RIA kit for plasma renin activity.

Glorioso N, Dessì-Fulgheri P, Madeddu P, Oppes M, Palermo M, Manca G, Turolo L, Morganti A, Rappelli A. Glorioso N, et al. Among authors: oppes m. J Nucl Med Allied Sci. 1985 Jul-Sep;29(3):235-9. J Nucl Med Allied Sci. 1985. PMID: 3908624 No abstract available.

2

Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensives.

Madeddu P, Oppes M, Rubattu S, Dessi'-Fulgheri P, Glorioso N, Soro A, Rappelli A. Madeddu P, et al. Among authors: oppes m. J Hypertens. 1987 Dec;5(6):645-8. doi: 10.1097/00004872-198712000-00002. J Hypertens. 1987. PMID: 3323316

3

Active and inactive renin during acute reduction of renal perfusion pressure in essential hypertensives.

Glorioso N, Dessì-Fulgheri P, Madeddu P, Urigo F, Tonolo GC, Oppes M, Palermo M, Rappelli A. Glorioso N, et al. Among authors: oppes m. Clin Exp Hypertens A. 1982;4(11-12):2293-302. doi: 10.3109/10641968209062391. Clin Exp Hypertens A. 1982. PMID: 6756697

4

Relation between urinary kallikrein excretion and blood pressure response to a single oral dose of captopril.

Madeddu P, Oppes M, Rubattu S, Bandiera F, Dessi-Fulgheri P, Glorioso N, Soro A, Troffa MC, Rappelli A. Madeddu P, et al. Among authors: oppes m. Clin Exp Hypertens A. 1987;9(2-3):615-21. doi: 10.3109/10641968709164233. Clin Exp Hypertens A. 1987. PMID: 3301084

5

The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.

Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Bandiera F, Manunta P, Rubattu S, Rappelli A. Madeddu P, et al. Among authors: oppes m. J Hypertens. 1987 Oct;5(5):581-6. doi: 10.1097/00004872-198710000-00012. J Hypertens. 1987. PMID: 2448367

6

Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.

Madeddu P, Oppes M, Rubattu S, Bandiera F, Dessi'-Fulgheri P, Glorioso N, Soro A, Chiara-Troffa M, Rappelli A. Madeddu P, et al. Among authors: oppes m. Agents Actions Suppl. 1987;22:321-8. doi: 10.1007/978-3-0348-9299-5_33. Agents Actions Suppl. 1987. PMID: 3324715

7

Comparison of sublingual and oral captopril in hypertension.

Dessì-Fulgheri P, Bandiera F, Rubattu S, Cocco F, Madeddu P, Oppes M, Tonolo GC, Glorioso N, Rappelli A. Dessì-Fulgheri P, et al. Among authors: oppes m. Clin Exp Hypertens A. 1987;9(2-3):593-7. doi: 10.3109/10641968709164229. Clin Exp Hypertens A. 1987. PMID: 3038422 Clinical Trial.

8

The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.

Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Manunta F, Rubatti S, Rappelli A. Madeddu P, et al. Among authors: oppes m. Agents Actions Suppl. 1987;22:373-80. Agents Actions Suppl. 1987. PMID: 2449054

9

Natriuretic effect of acute nifedipine administration is not mediated by the renal kallikrein-kinin system.

Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Bandiera F, Manunta P, Rubattu S, Troffa C, Tonolo GC, et al. Madeddu P, et al. Among authors: oppes m. J Cardiovasc Pharmacol. 1987 May;9(5):536-40. doi: 10.1097/00005344-198705000-00005. J Cardiovasc Pharmacol. 1987. PMID: 2439833 Clinical Trial.

10

Prokallikrein and kallikrein inhibitors in human urine.

Madeddu P, Oppes M, Rubattu S, Tonolo GC, Dessì-Fulgheri P, Glorioso N, Rappelli A. Madeddu P, et al. Among authors: oppes m. J Hypertens Suppl. 1985 Dec;3(3):S283-6. J Hypertens Suppl. 1985. PMID: 2856718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters